Quarterly report pursuant to Section 13 or 15(d)

Common Stock, Preferred Stock and Convertible Preferred Stock (Details)

v3.21.2
Common Stock, Preferred Stock and Convertible Preferred Stock (Details) - USD ($)
 1 Months Ended 6 Months Ended
Feb. 29, 2020
Aug. 31, 2019
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Oct. 31, 2019
Sep. 30, 2019
Common Stock, Preferred Stock and Convertible Preferred Stock (Details) [Line Items]              
Common stock, shares authorized     500,000,000   500,000,000    
Common stock par value (in Dollars per share)     $ 0.0001   $ 0.0001    
Lieu of issuing shares (in Dollars)     $ 7,000        
Preferred stock, shares authorized     10,000,000   10,000,000    
Preferred stock, par value (in Dollars per share)     $ 0.0001   $ 0.0001    
Exercisable and expire In February 2020, Private Augmedix raised $0.5 million in cash proceeds through issuance of 173,752 shares of Series B to certain existing shareholders and warrants to purchase up to 57,338 shares of Series B at a price of $2.88 per share, are immediately exercisable and expire in September 2029. At the Effective Time of the Merger, the warrants to purchase shares of Series B were converted to warrants to purchase 2,767,836 shares of common stock at a price of $2.88 per share, are immediately exercisable and expire in September 2029.          
Warrants to purchase shares 2,767,836         2,130,115  
Exercise price per share (in Dollars per share) $ 2.88            
Fair value of warrant liability (in Dollars)     $ 186,000      
Issued shares of convertible preferred stock     14,804,274        
Common Stock [Member]              
Common Stock, Preferred Stock and Convertible Preferred Stock (Details) [Line Items]              
Common stock share issued     2,166,667        
Warrant Liability [Member]              
Common Stock, Preferred Stock and Convertible Preferred Stock (Details) [Line Items]              
Fair value of warrant liability (in Dollars) $ 100,000            
Unaccredited Investor [Member[              
Common Stock, Preferred Stock and Convertible Preferred Stock (Details) [Line Items]              
Lieu of issuing shares (in Dollars)     $ 600,000        
Series B Preferred Stock [Member]              
Common Stock, Preferred Stock and Convertible Preferred Stock (Details) [Line Items]              
Cash proceeds (in Dollars) $ 500,000            
Issued shares of convertible preferred stock 173,752            
Warrants to purchase shares 57,338            
Exercise price per share (in Dollars per share) $ 2.88            
Issuance costs (in Dollars) $ 4,000            
Series B Preferred Stock [Member] | Sub Agreement [Member]              
Common Stock, Preferred Stock and Convertible Preferred Stock (Details) [Line Items]              
Warrants to purchase shares 57,338 580,383         2,130,115